Intensiv multifaktoriel behandling og mortalitet ved type 2- diabetes - Sekundærpublikation

Peter Haulund Gæde, Henrik Lund-Andersen, Hans Henrik Parving, Oluf Borbye Pedersen

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstract

    The Steno-2 Study has previously demonstrated marked risk reductions in cardiovascular disease with intensified polypharmacological treatment of patients with type 2 diabetes and microalbuminuria after 8 years of intensified multifactorial intervention. The present long-term follow-up demonstrates an absolute 20% risk reduction in total and 13% in cardiovascular mortality. Risk reductions for cardiovascular disease were even more pronounced after 13 years of follow-up than after 8 years. The earlier intensive treatment was initiated, the more patients seemed to benefit.

    Bidragets oversatte titelIntensive multifactorial treatment and mortality of patients with type 2 diabetes
    OriginalsprogDansk
    Sider (fra-til)952-955
    Antal sider4
    TidsskriftUgeskrift for laeger
    Vol/bind170
    Udgave nummer11
    StatusUdgivet - 10 mar. 2008

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Intensiv multifaktoriel behandling og mortalitet ved type 2- diabetes - Sekundærpublikation' indeholder.

    Citationsformater